Purpura, Thrombocytopenic, Idiopathic: all 521 studies

Page 1 of 6. Open to participants first (158), then studies with results posted, then the rest; newest registration first within each.

• Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07811622Not applicable
• Selective Mediterranean Diet in Immune ThrombocytopeniaNot yet recruitingNCT07798050Not applicable
• Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune ThrombocytopeniaRecruitingNCT07788456Phase 4
• A Study of Patients' Preferences for Primary Immune Thrombocytopenia TreatmentRecruitingNCT07786077
• Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasNot yet recruitingNCT07765966Phase 1
• A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHANot yet recruitingNCT07738822Phase 1/2
• SG301-SC Injection Safety Study in Subjects With Primary ITP PatientsRecruitingNCT07710248Phase 2
• A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)RecruitingNCT07700238Phase 3
• Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITPNot yet recruitingNCT07687134Phase 2
• Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile LupusNot yet recruitingNCT07680010Not applicable
• TPO-RA Plus Baricitinib vs. TPO-RA for ITPNot yet recruitingNCT07669675Phase 2
• Atorvastatin Combined With NAC Plus Romiplostim for Management of ITPNot yet recruitingNCT07662525Not applicable
• A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.Not yet recruitingNCT07660172Phase 2
• Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune ThrombocytopeniaRecruitingNCT07657793Phase 2/3
• A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT07622329Phase 1
• Romiplostim for Oral TPO-RA Resistant ITPRecruitingNCT07612319Not applicable
• Safety and Efficacy of GL-2045 in Patients With Immune ThrombocytopeniaRecruitingNCT07605845Phase 1
• Universal STAR-T Cell Injection in R/R Autoimmune Diseases.Not yet recruitingNCT07599280Phase 1
• ATRA for Management of Primary ITPNot yet recruitingNCT07597395Phase 3
• A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With EltrombopagRecruitingNCT07587723
• CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaNot yet recruitingNCT07574073Phase 1
• High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune ThrombocytopeniaRecruitingNCT07559331Phase 3
• Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune DiseaseRecruitingNCT07549698Phase 1/2
• rhTPO Dose Escalation vs Eltrombopag Switch in ITPNot yet recruitingNCT07476846Not applicable
• TGD001 Treatment in Thrombotic MicroangiopathiesNot yet recruitingNCT07459114Phase 1/2
• Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsNot yet recruitingNCT07455006Phase 3
• Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary RevascularizationNot yet recruitingNCT07426107
• A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)RecruitingNCT07421167Phase 2
• A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune ThrombocytopeniaNot yet recruitingNCT07416032Early Phase 1
• Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of TherapyNot yet recruitingNCT07400250Phase 2
• Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)RecruitingNCT07362238Phase 2
• Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)RecruitingNCT07362199Phase 2
• Optimal Dose of Zanubrutinib to Treat Adult Immune ThrombocytopeniaNot yet recruitingNCT07315373Phase 1
• Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic PurpuraNot yet recruitingNCT07310342Not applicable
• The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related ThrombocytopeniaNot yet recruitingNCT07298733
• Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)RecruitingNCT07297563Phase 2
• A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)RecruitingNCT07294365Phase 2
• Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune ThrombocytopeniaNot yet recruitingNCT07278908Phase 2/3
• National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) PatientsNot yet recruitingNCT07268898
• Managed Access Programs for VAY736, IanalumabAvailableNCT07244289
• Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)RecruitingNCT07234019Phase 2
• An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune ThrombocytopeniaRecruitingNCT07233213Phase 3
• A Study of CD19 UCAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07212322Not applicable
• Phase I Study of SHR-2173 Injection in Patients With Primary Immune ThrombocytopeniaRecruitingNCT07206758Phase 1
• An Exploratory Study of Golidocitinib in Adult Patients With ITPNot yet recruitingNCT07196163Phase 1/2
• A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07194850Phase 2/3
• Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITPNot yet recruitingNCT07189910Phase 4
• A Study of CM336 in Patients With Relapsed or Refractory Autoimmune CytopeniaRecruitingNCT07175493Phase 1/2
• An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07174843Early Phase 1
• Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot StudyRecruitingNCT07133659Phase 4
• Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell DisordersRecruitingNCT07104565Phase 2
• Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune ThrombocytopeniaRecruitingNCT07095127Phase 2
• Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic PurpuraRecruitingNCT07093606Not applicable
• OM336 in Autoimmune CytopeniasRecruitingNCT07083960Phase 1
• A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in AdultsNot yet recruitingNCT07083739Phase 2
• RN1201 Injection in the Treatment of Antibody-Mediated DiseasesRecruitingNCT07072247Phase 1
• Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic StrokeNot yet recruitingNCT07070193
• Longitudinal Observational Study on Immune ThrombocytopeniaNot yet recruitingNCT07068425
• The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)RecruitingNCT07065968Phase 2
• The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT07064889Phase 2
• Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)RecruitingNCT07063199Phase 2
• Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on TreatmentNot yet recruitingNCT07059910
• A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07059000Phase 3
• Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPNot yet recruitingNCT07057778Phase 2
• The Holistic StudyNot yet recruitingNCT07051915Phase 3
• Level of Serum Lactate Dehydrogenase in Immune ThrombocytopeniaNot yet recruitingNCT07046013
• A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)RecruitingNCT07043946Phase 1/2
• A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPYNot yet recruitingNCT07019545Phase 2
• A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaRecruitingNCT07017725Phase 1/2
• "Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"Not yet recruitingNCT07014904
• Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line TreatmentRecruitingNCT07007962Phase 3
• Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialRecruitingNCT06992128Phase 2
• Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaRecruitingNCT06973356Not applicable
• V-IMMUNE® for Immune ThrombocytopeniaRecruitingNCT06962631Phase 3
• A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
• A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)RecruitingNCT06929299Phase 1/2
• RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune ThrombocytopeniaRecruitingNCT06919341
• A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune ThrombocytopeniaRecruitingNCT06900920Phase 3
• Safety Study of CC312 in Autoimmune Disease PatientsRecruitingNCT06888960Early Phase 1
• Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in ChinaNot yet recruitingNCT06873672
• A Phase 1/2 Study of ESG206 in Patients With Primary Immune ThrombocytopeniaRecruitingNCT06853444Phase 1/2
• Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)RecruitingNCT06838962Phase 2
• Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune ThrombocytopeniaRecruitingNCT06826430Phase 1
• Cognitive Dysfunction in Chronic and Persistent Immune ThrombocytopeniaRecruitingNCT06817395
• An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune ThrombocytopeniaRecruitingNCT06799611Phase 2
• Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid FailureNot yet recruitingNCT06790888Not applicable
• BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune DiseasesRecruitingNCT06787989Phase 1
• A Clinical Study of NAD in the Treatment of Immune ThrombocytopeniaRecruitingNCT06776510Phase 1/2
• Special Drug Use-results Survey for Long-term Use (Fostamatinib)RecruitingNCT06757257
• Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
• Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Enrolling by invitationNCT06723106Phase 1
• A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
• A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaRecruitingNCT06721013Phase 1/2
• Role of Acute Phase Proteins In Diagnosis of Immune ThrombocytopeniaRecruitingNCT06715215Not applicable
• Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITPRecruitingNCT06686927Phase 2
• A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITPRecruitingNCT06658834Phase 2
• Steroid Resistance in Pediatric Immune Thrombocytopenic PurpuraNot yet recruitingNCT06601543
• Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
• Observatory of Immunological Thrombopenic Purpura in the Brest RegionRecruitingNCT06556888
• A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune ThrombocytopeniaRecruitingNCT06544499Phase 3

← Purpura, Thrombocytopenic, Idiopathic overview